Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care During EBUS Bronchoscopy
Prospective Study to Evaluate High Flow Nasal Cannula With Monitored Anesthesia Care
The Cooper Health System
198 participants
Feb 1, 2022
INTERVENTIONAL
Conditions
Summary
Our objective is to assess whether the use of high flow nasal cannula (Vapotherm, Exeter, NH) with monitored anesthesia care (MAC) during an endobronchial ultrasound (EBUS) bronchoscopy procedure will lead to less procedure interruptions, less hypoxic episodes, shorter duration of hypoxic episodes and shorter procedural durations when compared to regular MAC using a regular nasal canula.
Eligibility
Inclusion Criteria2
- age\>18 years
- patient undergoing EBUS bronchoscopy with moderate conscious sedation.
Exclusion Criteria5
- subjects with previous nasal surgeries
- subjects with oxygen saturation \<90% on room air prior to procedure
- subjects who are pregnant
- subjects with known facial fractures or recent facial trauma
- subjects on any anticoagulation that cannot be discontinued prior to the procedure
Interventions
Monitored anesthesia care with oxygen supplementation through a high-flow nasal cannula
Monitored anesthesia care with oxygen supplementation through a regular nasal cannula
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05203328